{
  "ticker": "AMGN",
  "last_updated": "2025-04-19T10:04:54.704574",
  "retention_years": 3,
  "count": 1090,
  "transactions": [
    {
      "id": 319505,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2025-03-17",
      "transaction_shares": "489",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "9340"
    },
    {
      "id": 319519,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2025-03-17",
      "transaction_shares": "174",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "5117"
    },
    {
      "id": 319524,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2025-03-17",
      "transaction_shares": "524",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "8214"
    },
    {
      "id": 319527,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2025-03-17",
      "transaction_shares": "12853",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "587565"
    },
    {
      "id": 319546,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3635",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "40702"
    },
    {
      "id": 319556,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2025-03-17",
      "transaction_shares": "930",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "9654"
    },
    {
      "id": 319568,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2025-03-17",
      "transaction_shares": "4039",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "48386"
    },
    {
      "id": 319587,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3150",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "32266"
    },
    {
      "id": 319608,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3393",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "75075"
    },
    {
      "id": 319610,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3305",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "40334"
    },
    {
      "id": 366081,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2025-03-17",
      "transaction_shares": "489",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "9340"
    },
    {
      "id": 366095,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2025-03-17",
      "transaction_shares": "174",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "5117"
    },
    {
      "id": 366100,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2025-03-17",
      "transaction_shares": "524",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "8214"
    },
    {
      "id": 366103,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2025-03-17",
      "transaction_shares": "12853",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "587565"
    },
    {
      "id": 366122,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3635",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "40702"
    },
    {
      "id": 366132,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2025-03-17",
      "transaction_shares": "930",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "9654"
    },
    {
      "id": 366144,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2025-03-17",
      "transaction_shares": "4039",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "48386"
    },
    {
      "id": 366163,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3150",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "32266"
    },
    {
      "id": 366184,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3393",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "75075"
    },
    {
      "id": 366186,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2025-03-17",
      "transaction_shares": "3305",
      "transaction_price": "313.71",
      "transaction_type": "F",
      "shares_after_transaction": "40334"
    },
    {
      "id": 319497,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2025-03-03",
      "transaction_shares": "1403",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9802"
    },
    {
      "id": 319504,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2025-03-03",
      "transaction_shares": "25734",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "599925"
    },
    {
      "id": 319532,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2025-03-03",
      "transaction_shares": "497",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5277"
    },
    {
      "id": 319538,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2025-03-03",
      "transaction_shares": "8085",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52271"
    },
    {
      "id": 319550,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2025-03-03",
      "transaction_shares": "6306",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35293"
    },
    {
      "id": 319554,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2025-03-03",
      "transaction_shares": "1503",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8713"
    },
    {
      "id": 319564,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2025-03-03",
      "transaction_shares": "6792",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78338"
    },
    {
      "id": 319571,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2025-03-03",
      "transaction_shares": "2005",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10549"
    },
    {
      "id": 319572,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2025-03-03",
      "transaction_shares": "7277",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "43502"
    },
    {
      "id": 319585,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2025-03-03",
      "transaction_shares": "7277",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44199"
    },
    {
      "id": 366073,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2025-03-03",
      "transaction_shares": "1403",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9802"
    },
    {
      "id": 366080,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2025-03-03",
      "transaction_shares": "25734",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "599925"
    },
    {
      "id": 366108,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2025-03-03",
      "transaction_shares": "497",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5277"
    },
    {
      "id": 366114,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2025-03-03",
      "transaction_shares": "8085",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52271"
    },
    {
      "id": 366126,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2025-03-03",
      "transaction_shares": "6306",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35293"
    },
    {
      "id": 366130,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2025-03-03",
      "transaction_shares": "1503",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8713"
    },
    {
      "id": 366140,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2025-03-03",
      "transaction_shares": "6792",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78338"
    },
    {
      "id": 366147,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2025-03-03",
      "transaction_shares": "2005",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10549"
    },
    {
      "id": 366148,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2025-03-03",
      "transaction_shares": "7277",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "43502"
    },
    {
      "id": 366161,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2025-03-03",
      "transaction_shares": "7277",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "44199"
    },
    {
      "id": 276770,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2025-02-19",
      "transaction_shares": "8711",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "70858"
    },
    {
      "id": 276791,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2025-02-19",
      "transaction_shares": "8711",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "80257"
    },
    {
      "id": 319565,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2025-02-19",
      "transaction_shares": "8711",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "70858"
    },
    {
      "id": 319591,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2025-02-19",
      "transaction_shares": "8711",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "80257"
    },
    {
      "id": 366141,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2025-02-19",
      "transaction_shares": "8711",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "70858"
    },
    {
      "id": 366167,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2025-02-19",
      "transaction_shares": "8711",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "80257"
    },
    {
      "id": 276767,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2025-02-18",
      "transaction_shares": "500",
      "transaction_price": "292.5584",
      "transaction_type": "S",
      "shares_after_transaction": "8544"
    },
    {
      "id": 319561,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2025-02-18",
      "transaction_shares": "500",
      "transaction_price": "292.5584",
      "transaction_type": "S",
      "shares_after_transaction": "8544"
    },
    {
      "id": 366137,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2025-02-18",
      "transaction_shares": "500",
      "transaction_price": "292.5584",
      "transaction_type": "S",
      "shares_after_transaction": "8544"
    },
    {
      "id": 276774,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2025-02-11",
      "transaction_shares": "8771",
      "transaction_price": "294.7947",
      "transaction_type": "S",
      "shares_after_transaction": "44186"
    },
    {
      "id": 319570,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2025-02-11",
      "transaction_shares": "8771",
      "transaction_price": "294.7947",
      "transaction_type": "S",
      "shares_after_transaction": "44186"
    },
    {
      "id": 366146,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2025-02-11",
      "transaction_shares": "8771",
      "transaction_price": "294.7947",
      "transaction_type": "S",
      "shares_after_transaction": "44186"
    },
    {
      "id": 276778,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2025-02-07",
      "transaction_shares": "25045",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "54032"
    },
    {
      "id": 319576,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2025-02-07",
      "transaction_shares": "25045",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "54032"
    },
    {
      "id": 366152,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2025-02-07",
      "transaction_shares": "25045",
      "transaction_price": "156.35",
      "transaction_type": "M",
      "shares_after_transaction": "54032"
    },
    {
      "id": 276727,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2025-02-05",
      "transaction_shares": "1589",
      "transaction_price": "304.4731",
      "transaction_type": "S",
      "shares_after_transaction": "7210"
    },
    {
      "id": 319512,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2025-02-05",
      "transaction_shares": "1589",
      "transaction_price": "304.4731",
      "transaction_type": "S",
      "shares_after_transaction": "7210"
    },
    {
      "id": 366088,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2025-02-05",
      "transaction_shares": "1589",
      "transaction_price": "304.4731",
      "transaction_type": "S",
      "shares_after_transaction": "7210"
    },
    {
      "id": 205821,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-12-05",
      "transaction_shares": "6430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "28903"
    },
    {
      "id": 239589,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-12-05",
      "transaction_shares": "6430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "28903"
    },
    {
      "id": 276803,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-12-05",
      "transaction_shares": "6430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "28903"
    },
    {
      "id": 319603,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-12-05",
      "transaction_shares": "6430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "28903"
    },
    {
      "id": 366179,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-12-05",
      "transaction_shares": "6430",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "28903"
    },
    {
      "id": 205776,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-12-02",
      "transaction_shares": "96000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "573855"
    },
    {
      "id": 239544,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-12-02",
      "transaction_shares": "96000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "573855"
    },
    {
      "id": 276753,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-12-02",
      "transaction_shares": "96000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "573855"
    },
    {
      "id": 319543,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-12-02",
      "transaction_shares": "96000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "573855"
    },
    {
      "id": 366119,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-12-02",
      "transaction_shares": "96000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "573855"
    },
    {
      "id": 174469,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-11-05",
      "transaction_shares": "212",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "8383"
    },
    {
      "id": 174495,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-11-05",
      "transaction_shares": "189",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "4770"
    },
    {
      "id": 205788,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-11-05",
      "transaction_shares": "212",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "8383"
    },
    {
      "id": 205814,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-11-05",
      "transaction_shares": "189",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "4770"
    },
    {
      "id": 239556,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-11-05",
      "transaction_shares": "212",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "8383"
    },
    {
      "id": 239582,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-11-05",
      "transaction_shares": "189",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "4770"
    },
    {
      "id": 276765,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-11-05",
      "transaction_shares": "212",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "8383"
    },
    {
      "id": 276796,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-11-05",
      "transaction_shares": "189",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "4770"
    },
    {
      "id": 319559,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-11-05",
      "transaction_shares": "212",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "8383"
    },
    {
      "id": 319596,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-11-05",
      "transaction_shares": "189",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "4770"
    },
    {
      "id": 366135,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-11-05",
      "transaction_shares": "212",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "8383"
    },
    {
      "id": 366172,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-11-05",
      "transaction_shares": "189",
      "transaction_price": "316.91",
      "transaction_type": "F",
      "shares_after_transaction": "4770"
    },
    {
      "id": 174451,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5081.0807"
    },
    {
      "id": 174496,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3552.1796"
    },
    {
      "id": 174503,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "268.215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10114.0229"
    },
    {
      "id": 205769,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5081.0807"
    },
    {
      "id": 205815,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3552.1796"
    },
    {
      "id": 205823,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "268.215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10114.0229"
    },
    {
      "id": 239537,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5081.0807"
    },
    {
      "id": 239583,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3552.1796"
    },
    {
      "id": 239591,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "268.215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10114.0229"
    },
    {
      "id": 276746,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5081.0807"
    },
    {
      "id": 276797,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3552.1796"
    },
    {
      "id": 276805,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "268.215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10114.0229"
    },
    {
      "id": 319535,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5081.0807"
    },
    {
      "id": 319597,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3552.1796"
    },
    {
      "id": 319605,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "268.215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10114.0229"
    },
    {
      "id": 366111,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "5081.0807"
    },
    {
      "id": 366173,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "220.8829",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3552.1796"
    },
    {
      "id": 366181,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-04",
      "transaction_shares": "268.215",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10114.0229"
    },
    {
      "id": 94041,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 94074,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 94092,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 118872,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 118905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 118923,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 145605,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 145638,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 145656,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 174442,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 174477,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 174497,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 205760,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 205796,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 205816,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 239528,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 239564,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 239584,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 276737,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 276776,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 276798,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 319523,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 319574,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 319598,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 366099,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "131.787",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9776.8079"
    },
    {
      "id": 366150,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4833.1978"
    },
    {
      "id": 366174,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-09",
      "transaction_shares": "108.5305",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3307.2967"
    },
    {
      "id": 94051,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 118882,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 145615,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 174453,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 205771,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 239539,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 276748,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 319537,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 366113,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-07-31",
      "transaction_shares": "1565",
      "transaction_price": "333.28",
      "transaction_type": "F",
      "shares_after_transaction": "8771"
    },
    {
      "id": 50856,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 50857,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 50873,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 50885,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 50892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 50895,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 50898,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 50902,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 50907,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 50909,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 50918,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 71365,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 71366,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 71382,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 71394,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 71401,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 71404,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 71407,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 71411,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 71416,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 71418,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 71427,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 94034,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 94035,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 94053,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 94065,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 94072,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 94076,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 94079,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 94083,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 94088,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 94090,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 94100,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 118865,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 118866,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 118884,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 118896,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 118903,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 118907,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 118910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 118914,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 118919,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 118921,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 118931,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 145598,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 145599,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 145617,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 145629,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 145636,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 145640,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 145643,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 145647,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 145652,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 145654,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 145664,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 174435,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 174436,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 174455,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 174467,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 174475,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 174479,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 174482,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 174486,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 174491,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 174493,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 174506,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 205753,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 205754,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 205773,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 205786,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 205794,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 205798,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 205801,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 205805,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 205810,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 205812,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 205826,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 239521,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 239522,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 239541,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 239554,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 239562,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 239566,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 239569,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 239573,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 239578,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 239580,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 239594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 276730,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 276731,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 276750,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 276763,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 276773,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 276779,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 276782,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 276786,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 276792,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 276794,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 276808,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 319515,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 319516,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 319540,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 319557,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 319569,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 319577,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 319580,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 319584,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 319592,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 319594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 319609,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 366091,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9574.0209"
    },
    {
      "id": 366092,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ECKERT ROBERT",
      "reporting_owner_cik": "0001194256",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "23715"
    },
    {
      "id": 366116,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Garland Greg C.",
      "reporting_owner_cik": "0001503107",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12374"
    },
    {
      "id": 366133,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "MILES AMY E",
      "reporting_owner_cik": "0001248617",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3927"
    },
    {
      "id": 366145,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Druker Brian",
      "reporting_owner_cik": "0001740205",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6472"
    },
    {
      "id": 366153,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Austin Wanda M",
      "reporting_owner_cik": "0001690882",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6544"
    },
    {
      "id": 366156,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Jacks Tyler",
      "reporting_owner_cik": "0001464237",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16005"
    },
    {
      "id": 366160,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Klotman Mary E.",
      "reporting_owner_cik": "0002020575",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "719"
    },
    {
      "id": 366168,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Kullman Ellen Jamison",
      "reporting_owner_cik": "0001303141",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12299.9807"
    },
    {
      "id": 366170,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4695.6673"
    },
    {
      "id": 366185,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-31",
      "transaction_shares": "719",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3174.7662"
    },
    {
      "id": 32871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 32875,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 32881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 32887,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 32902,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 32903,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 32909,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 32916,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 32920,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 32922,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 32925,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 32927,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 32928,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 32931,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 50842,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 50846,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 50852,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 50860,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 50876,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 50877,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 50883,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 50891,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 50897,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 50900,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 50904,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 50906,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 50908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 50912,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 71351,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 71355,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 71361,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 71369,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 71385,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 71386,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 71392,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 71400,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 71406,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 71409,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 71413,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 71415,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 71417,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 71421,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 94020,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 94024,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 94030,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 94038,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 94056,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 94057,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 94063,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 94071,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 94078,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 94081,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 94085,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 94087,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 94089,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 94094,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 118851,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 118855,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 118861,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 118869,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 118887,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 118888,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 118894,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 118902,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 118909,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 118912,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 118916,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 118918,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 118920,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 118925,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 145584,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 145588,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 145594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 145602,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 145620,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 145621,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 145627,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 145635,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 145642,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 145645,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 145649,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 145651,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 145653,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 145658,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 174421,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 174425,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 174431,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 174439,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 174458,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 174459,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 174465,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 174474,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 174481,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 174484,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 174488,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 174490,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 174492,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 174499,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 205739,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 205743,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 205749,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 205757,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 205777,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 205778,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 205784,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 205793,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 205800,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 205803,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 205807,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 205809,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 205811,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 205818,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 239507,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 239511,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 239517,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 239525,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 239545,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 239546,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 239552,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 239561,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 239568,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 239571,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 239575,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 239577,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 239579,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 239586,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 276715,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 276719,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 276725,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 276734,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 276754,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 276755,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 276761,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 276772,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 276781,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 276784,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 276788,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 276790,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 276793,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 276800,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 319498,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 319502,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 319510,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 319520,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 319544,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 319545,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 319553,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 319567,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 319579,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 319582,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 319588,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 319590,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 319593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 319600,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 366074,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11988",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669269"
    },
    {
      "id": 366078,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "499",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10300"
    },
    {
      "id": 366086,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3529",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "52674"
    },
    {
      "id": 366096,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2997",
      "transaction_price": "300.30",
      "transaction_type": "A",
      "shares_after_transaction": "71304"
    },
    {
      "id": 366120,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "333",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4932"
    },
    {
      "id": 366121,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "HOLLEY CHARLES M",
      "reporting_owner_cik": "0001216478",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "141.5251",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8855.0209"
    },
    {
      "id": 366129,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "532",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8559"
    },
    {
      "id": 366143,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-07",
      "transaction_shares": "865",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8983"
    },
    {
      "id": 366155,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35973"
    },
    {
      "id": 366158,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "ISHRAK OMAR",
      "reporting_owner_cik": "0001523102",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3976.6673"
    },
    {
      "id": 366164,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Drake Michael V",
      "reporting_owner_cik": "0001938942",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-07",
      "transaction_shares": "116.5501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2455.7662"
    },
    {
      "id": 366166,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25438"
    },
    {
      "id": 366169,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3196",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "61889"
    },
    {
      "id": 366176,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2863",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35186"
    },
    {
      "id": 32874,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 32876,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 32882,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 32883,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 32885,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 32899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 32906,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 32923,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 32930,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 32933,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 50845,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 50847,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 50853,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 50854,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 50858,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 50872,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 50880,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 50901,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 50911,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 50914,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 71354,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 71356,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 71362,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 71363,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 71367,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 71381,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 71389,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 71410,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 71420,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 71423,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 94023,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 94025,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 94031,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 94032,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 94036,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 94052,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 94060,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 94082,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 94093,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 94096,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 118854,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 118856,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 118862,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 118863,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 118867,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 118883,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 118891,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 118913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 118924,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 118927,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 145587,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 145589,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 145595,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 145596,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 145600,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 145616,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 145624,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 145646,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 145657,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 145660,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 174424,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 174426,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 174432,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 174433,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 174437,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 174454,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 174462,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 174485,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 174498,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 174501,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 205742,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 205744,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 205750,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 205751,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 205755,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 205772,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 205781,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 205804,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 205817,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 205820,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 239510,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 239512,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 239518,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 239519,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 239523,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 239540,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 239549,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 239572,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 239585,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 239588,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 276718,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 276720,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 276726,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 276728,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 276732,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 276749,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 276758,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 276785,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 276799,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 276802,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 319501,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 319503,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 319511,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 319513,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 319517,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 319539,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 319549,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 319583,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 319599,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 319602,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 366077,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-05",
      "transaction_shares": "632",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32323"
    },
    {
      "id": 366079,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-05",
      "transaction_shares": "665",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "49145"
    },
    {
      "id": 366087,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-05",
      "transaction_shares": "617",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "68307"
    },
    {
      "id": 366089,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-05",
      "transaction_shares": "41",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8027"
    },
    {
      "id": 366093,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "27",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "4599"
    },
    {
      "id": 366115,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "648",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "32777"
    },
    {
      "id": 366125,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-05",
      "transaction_shares": "633",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "58693"
    },
    {
      "id": 366159,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-05",
      "transaction_shares": "2220",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "657281"
    },
    {
      "id": 366175,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-05",
      "transaction_shares": "82",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "9801"
    },
    {
      "id": 366178,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-05",
      "transaction_shares": "78",
      "transaction_price": "311.29",
      "transaction_type": "F",
      "shares_after_transaction": "8118"
    },
    {
      "id": 32936,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 50917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 71426,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 94099,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 118930,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 145663,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 174505,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 205825,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 239593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 276807,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 319607,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 366183,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "2117",
      "transaction_price": "313.0853",
      "transaction_type": "S",
      "shares_after_transaction": "9883"
    },
    {
      "id": 32873,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 32879,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 32884,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 32888,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 32893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 32896,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 32904,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 32914,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 32924,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 32934,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 50844,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 50850,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 50855,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 50861,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 50866,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 50869,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 50878,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 50889,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 50903,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 50915,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 71353,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 71359,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 71364,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 71370,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 71375,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 71378,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 71387,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 71398,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 71412,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 71424,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 94022,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 94028,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 94033,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 94039,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 94045,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 94048,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 94058,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 94069,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 94084,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 94097,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 118853,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 118859,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 118864,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 118870,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 118876,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 118879,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 118889,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 118900,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 118915,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 118928,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 145586,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 145592,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 145597,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 145603,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 145609,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 145612,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 145622,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 145633,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 145648,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 145661,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 174423,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 174429,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 174434,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 174440,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 174446,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 174449,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 174460,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 174472,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 174487,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 174502,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 205741,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 205747,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 205752,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 205758,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 205764,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 205767,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 205779,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 205791,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 205806,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 205822,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 239509,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 239515,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 239520,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 239526,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 239532,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 239535,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 239547,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 239559,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 239574,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 239590,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 276717,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 276723,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 276729,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 276735,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 276741,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 276744,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 276756,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 276769,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 276787,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 276804,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 319500,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 319508,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 319514,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 319521,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 319529,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 319533,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 319547,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 319563,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 319586,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 319604,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 366076,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "27",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "4626"
    },
    {
      "id": 366084,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-05-02",
      "transaction_shares": "152",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8196"
    },
    {
      "id": 366090,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-05-02",
      "transaction_shares": "74",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "8068"
    },
    {
      "id": 366097,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-05-02",
      "transaction_shares": "606",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "68924"
    },
    {
      "id": 366105,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "114",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "12000"
    },
    {
      "id": 366109,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-05-02",
      "transaction_shares": "758",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "49810"
    },
    {
      "id": 366123,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-05-02",
      "transaction_shares": "2294",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "659501"
    },
    {
      "id": 366139,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-05-02",
      "transaction_shares": "650",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "59326"
    },
    {
      "id": 366162,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-05-02",
      "transaction_shares": "591",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "32955"
    },
    {
      "id": 366180,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-05-02",
      "transaction_shares": "682",
      "transaction_price": "277.37",
      "transaction_type": "F",
      "shares_after_transaction": "33425"
    },
    {
      "id": 32872,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 32878,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 32880,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 32894,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 32895,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 32897,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 32900,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 32901,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 32911,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 32912,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 50843,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 50849,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 50851,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 50867,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 50868,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 50870,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 50874,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 50875,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 50886,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 50887,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 71352,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 71358,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 71360,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 71376,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 71377,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 71379,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 71383,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 71384,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 71395,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 71396,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 94021,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 94027,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 94029,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 94046,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 94047,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 94049,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 94054,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 94055,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 94066,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 94067,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 118852,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 118858,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 118860,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 118877,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 118878,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 118880,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 118885,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 118886,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 118897,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 118898,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 145585,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 145591,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 145593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 145610,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 145611,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 145613,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 145618,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 145619,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 145630,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 145631,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 174422,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 174428,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 174430,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 174447,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 174448,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 174450,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 174456,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 174457,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 174468,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 174470,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 205740,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 205746,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 205748,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 205765,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 205766,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 205768,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 205774,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 205775,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 205787,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 205789,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 239508,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 239514,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 239516,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 239533,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 239534,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 239536,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 239542,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 239543,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 239555,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 239557,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 276716,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 276722,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 276724,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 276742,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 276743,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 276745,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 276751,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 276752,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 276764,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 276766,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 319499,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 319507,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 319509,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 319530,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 319531,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 319534,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 319541,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 319542,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 319558,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 319560,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 366075,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "603",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "34107"
    },
    {
      "id": 366083,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "690",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "59976"
    },
    {
      "id": 366085,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "17",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "4653"
    },
    {
      "id": 366106,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-04-30",
      "transaction_shares": "753",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "50568"
    },
    {
      "id": 366107,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-04-30",
      "transaction_shares": "71",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8348"
    },
    {
      "id": 366110,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-04-30",
      "transaction_shares": "2282",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "661795"
    },
    {
      "id": 366117,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-04-30",
      "transaction_shares": "686",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "33546"
    },
    {
      "id": 366118,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-04-30",
      "transaction_shares": "48",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "8142"
    },
    {
      "id": 366134,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-04-30",
      "transaction_shares": "683",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "69530"
    },
    {
      "id": 366136,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-04-30",
      "transaction_shares": "106",
      "transaction_price": "276.38",
      "transaction_type": "F",
      "shares_after_transaction": "12114"
    },
    {
      "id": 7588,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 7589,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 7591,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 7593,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 7594,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 7597,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 7601,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 7603,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 7606,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 7608,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 18752,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 18753,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 18755,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 18757,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 18758,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 18761,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 18765,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 18767,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 18770,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 18772,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 32877,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 32886,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 32890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 32892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 32898,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 32908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 32917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 32919,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 32929,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 32935,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 50848,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 50859,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 50863,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 50865,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 50871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 50882,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 50893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 50896,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 50910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 50916,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 71357,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 71368,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 71372,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 71374,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 71380,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 71391,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 71402,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 71405,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 71419,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 71425,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 94026,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 94037,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 94042,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 94044,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 94050,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 94062,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 94073,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 94077,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 94091,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 94098,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 118857,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 118868,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 118873,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 118875,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 118881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 118893,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 118904,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 118908,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 118922,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 118929,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 145590,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 145601,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 145606,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 145608,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 145614,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 145626,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 145637,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 145641,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 145655,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 145662,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 174427,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 174438,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 174443,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 174445,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 174452,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 174464,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 174476,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 174480,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 174494,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 174504,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 205745,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 205756,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 205761,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 205763,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 205770,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 205783,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 205795,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 205799,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 205813,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 205824,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 239513,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 239524,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 239529,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 239531,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 239538,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 239551,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 239563,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 239567,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 239581,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 239592,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 276721,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 276733,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 276738,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 276740,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 276747,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 276760,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 276775,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 276780,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 276795,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 276806,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 319506,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 319518,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 319525,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 319528,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 319536,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 319552,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 319573,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 319578,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 319595,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 319606,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 366082,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5168",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34710"
    },
    {
      "id": 366094,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-18",
      "transaction_shares": "438",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8190"
    },
    {
      "id": 366101,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-18",
      "transaction_shares": "20560",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "664077"
    },
    {
      "id": 366104,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "146",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "4670"
    },
    {
      "id": 366112,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-18",
      "transaction_shares": "475",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "8419"
    },
    {
      "id": 366128,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6137",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "70213"
    },
    {
      "id": 366149,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-18",
      "transaction_shares": "5879",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "34232"
    },
    {
      "id": 366154,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6202",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "60666"
    },
    {
      "id": 366171,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-18",
      "transaction_shares": "703",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "12220"
    },
    {
      "id": 366182,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-18",
      "transaction_shares": "6461",
      "transaction_price": "268.87",
      "transaction_type": "F",
      "shares_after_transaction": "51321"
    },
    {
      "id": 7590,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 7592,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 7595,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 7596,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 7598,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 7599,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 7600,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 7602,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 7604,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 7607,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 18754,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 18756,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 18759,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 18760,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 18762,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 18763,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 18764,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 18766,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 18768,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 18771,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 32889,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 32891,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 32905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 32907,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 32910,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 32913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 32915,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 32918,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 32921,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 32932,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 50862,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 50864,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 50879,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 50881,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 50884,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 50888,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 50890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 50894,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 50899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 50913,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 71371,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 71373,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 71388,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 71390,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 71393,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 71397,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 71399,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 71403,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 71408,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 71422,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 94040,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 94043,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 94059,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 94061,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 94064,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 94068,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 94070,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 94075,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 94080,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 94095,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 118871,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 118874,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 118890,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 118892,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 118895,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 118899,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 118901,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 118906,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 118911,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 118926,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 145604,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 145607,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 145623,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 145625,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 145628,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 145632,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 145634,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 145639,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 145644,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 145659,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 174441,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 174444,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 174461,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 174463,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 174466,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 174471,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 174473,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 174478,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 174483,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 174500,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 205759,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 205762,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 205780,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 205782,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 205785,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 205790,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 205792,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 205797,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 205802,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 205819,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 239527,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 239530,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 239548,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 239550,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 239553,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 239558,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 239560,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 239565,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 239570,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 239587,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 276736,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 276739,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 276757,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 276759,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 276762,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 276768,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 276771,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 276777,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 276783,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 276801,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 319522,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 319526,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 319548,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 319551,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 319555,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 319562,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 319566,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 319575,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 319581,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 319601,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 366098,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Santos Esteban",
      "reporting_owner_cik": "0001677950",
      "reporting_owner_position": "EVP, Operations",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12278",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "76125"
    },
    {
      "id": 366102,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Graham Jonathan P",
      "reporting_owner_cik": "0001365306",
      "reporting_owner_position": "EVP & Gen. Counsel & Secy.",
      "transaction_date": "2024-03-06",
      "transaction_shares": "11760",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39925"
    },
    {
      "id": 366124,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "REESE DAVID M",
      "reporting_owner_cik": "0001748434",
      "reporting_owner_position": "EVP & Chief Technology Officer",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12407",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "66653"
    },
    {
      "id": 366127,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradway Robert A",
      "reporting_owner_cik": "0001396482",
      "reporting_owner_position": "Chairman, CEO and President",
      "transaction_date": "2024-03-06",
      "transaction_shares": "41133",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "683910"
    },
    {
      "id": 366131,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Grygiel Nancy A.",
      "reporting_owner_cik": "0001816414",
      "reporting_owner_position": "SVP & CCO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1954",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12866"
    },
    {
      "id": 366138,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Gordon Murdo",
      "reporting_owner_cik": "0001642156",
      "reporting_owner_position": "EVP, Global Commercial Ops",
      "transaction_date": "2024-03-06",
      "transaction_shares": "12924",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "57569"
    },
    {
      "id": 366142,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Busch Matthew C.",
      "reporting_owner_cik": "0001987926",
      "reporting_owner_position": "VP, Finance & CAO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "418",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4799"
    },
    {
      "id": 366151,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Griffith Peter H.",
      "reporting_owner_cik": "0001798821",
      "reporting_owner_position": "EVP & CFO",
      "transaction_date": "2024-03-06",
      "transaction_shares": "10338",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "39250"
    },
    {
      "id": 366157,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Miller Derek",
      "reporting_owner_cik": "0001917312",
      "reporting_owner_position": "SVP, Human Resources",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1311",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8863"
    },
    {
      "id": 366177,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Khosla Rachna",
      "reporting_owner_cik": "0001881332",
      "reporting_owner_position": "SVP, Business Development",
      "transaction_date": "2024-03-06",
      "transaction_shares": "1256",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8597"
    },
    {
      "id": 1215,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 7605,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 18769,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 32926,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 50905,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 71414,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 94086,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 118917,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 145650,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 174489,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 205808,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 239576,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 276789,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 319589,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    },
    {
      "id": 366165,
      "issuer_name": "AMGEN INC",
      "reporting_owner": "Bradner James E.",
      "reporting_owner_cik": "0002005159",
      "reporting_owner_position": "EVP, R&D, & Chief Sci. Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8587",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8587"
    }
  ]
}